Therapeutic effectiveness against MOPC-315 plasmacytoma of low or high doses of the synthetic thymic hormone THF-gamma 2 in combination with an "immunomodulating" or a "non-immunomodulating" drug.

Source:http://linkedlifedata.com/resource/pubmed/id/2019463

Int. J. Cancer 1991 Apr 22 48 1 96-100

Download in:

View as

General Info

PMID
2019463